Association between electronic nicotine delivery systems and electronic non-nicotine delivery systems with initiation of tobacco use in individuals aged < 20 years. A systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
04
2021
accepted:
23
07
2021
entrez:
8
9
2021
pubmed:
9
9
2021
medline:
15
12
2021
Statut:
epublish
Résumé
This systematic review described the association between electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS) use among non-smoking children and adolescents aged <20 years with subsequent tobacco use. We searched five electronic databases and the grey literature up to end of September 2020. Prospective longitudinal studies that described the association between ENDS/ENNDS use, and subsequent tobacco use in those aged < 20 years who were non-smokers at baseline were included. The Joanna Briggs Institute Critical Appraisal Checklist was used to assess risk of bias. Data were extracted by two reviewers and pooled using a random-effects meta-analysis. We generated unadjusted and adjusted risk ratios (ARRs) describing associations between ENDS/ENNDS and tobacco use. A total of 36 publications met the eligibility criteria, of which 25 were included in the systematic review (23 in the meta-analysis) after exclusion of overlapping studies. Sixteen studies had high to moderate risk of bias. Ever users of ENDS/ENNDS had over three times the risk of ever cigarette use (ARR 3·01 (95% CI: 2·37, 3·82; p<0·001, I2: 82·3%), and current cigarette use had over two times the risk (ARR 2·56 (95% CI: 1·61, 4·07; p<0·001, I2: 77·3%) at follow up. Among current ENDS/ENNDS users, there was a significant association with ever (ARR 2·63 (95% CI: 1·94, 3·57; p<0·001, I2: 21·2%)), but not current cigarette use (ARR 1·88 (95% CI: 0·34, 10·30; p = 0·47, I2: 0%)) at follow up. For other tobacco use, ARR ranged between 1·55 (95% CI 1·07, 2·23) and 8·32 (95% CI: 1·20, 57·04) for waterpipe and pipes, respectively. Additionally, two studies examined the use of ENNDS (non-nicotine devices) and found a pooled adjusted RR of 2·56 (95% CI: 0·47, 13·94, p = 0.035). There is an urgent need for policies that regulate the availability, accessibility, and marketing of ENDS/ENNDS to children and adolescents. Governments should also consider adopting policies to prevent ENDS/ENNDS uptake and use in children and adolescents, up to and including a ban for this group.
Sections du résumé
BACKGROUND
This systematic review described the association between electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS) use among non-smoking children and adolescents aged <20 years with subsequent tobacco use.
METHODS
We searched five electronic databases and the grey literature up to end of September 2020. Prospective longitudinal studies that described the association between ENDS/ENNDS use, and subsequent tobacco use in those aged < 20 years who were non-smokers at baseline were included. The Joanna Briggs Institute Critical Appraisal Checklist was used to assess risk of bias. Data were extracted by two reviewers and pooled using a random-effects meta-analysis. We generated unadjusted and adjusted risk ratios (ARRs) describing associations between ENDS/ENNDS and tobacco use.
FINDINGS
A total of 36 publications met the eligibility criteria, of which 25 were included in the systematic review (23 in the meta-analysis) after exclusion of overlapping studies. Sixteen studies had high to moderate risk of bias. Ever users of ENDS/ENNDS had over three times the risk of ever cigarette use (ARR 3·01 (95% CI: 2·37, 3·82; p<0·001, I2: 82·3%), and current cigarette use had over two times the risk (ARR 2·56 (95% CI: 1·61, 4·07; p<0·001, I2: 77·3%) at follow up. Among current ENDS/ENNDS users, there was a significant association with ever (ARR 2·63 (95% CI: 1·94, 3·57; p<0·001, I2: 21·2%)), but not current cigarette use (ARR 1·88 (95% CI: 0·34, 10·30; p = 0·47, I2: 0%)) at follow up. For other tobacco use, ARR ranged between 1·55 (95% CI 1·07, 2·23) and 8·32 (95% CI: 1·20, 57·04) for waterpipe and pipes, respectively. Additionally, two studies examined the use of ENNDS (non-nicotine devices) and found a pooled adjusted RR of 2·56 (95% CI: 0·47, 13·94, p = 0.035).
CONCLUSION
There is an urgent need for policies that regulate the availability, accessibility, and marketing of ENDS/ENNDS to children and adolescents. Governments should also consider adopting policies to prevent ENDS/ENNDS uptake and use in children and adolescents, up to and including a ban for this group.
Identifiants
pubmed: 34495974
doi: 10.1371/journal.pone.0256044
pii: PONE-D-21-11245
pmc: PMC8425526
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0256044Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Drug Alcohol Depend. 2019 Aug 1;201:85-93
pubmed: 31200279
BMC Public Health. 2020 Oct 9;20(1):1518
pubmed: 33032554
Eur J Epidemiol. 2018 Mar;33(3):323-334
pubmed: 29260431
JAMA Netw Open. 2019 Feb 1;2(2):e187794
pubmed: 30707232
Eur J Prev Cardiol. 2020 Jul 29;:2047487320941993
pubmed: 32726563
Curr Cardiol Rep. 2019 Aug 28;21(10):111
pubmed: 31463564
Tob Control. 2017 Jul;26(4):440-445
pubmed: 27903958
Nicotine Tob Res. 2019 Sep 19;21(10):1320-1330
pubmed: 29788314
Dtsch Arztebl Int. 2018 Apr 6;115(14):243-248
pubmed: 29716689
Evid Based Med. 2016 Aug;21(4):125-7
pubmed: 27339128
Pediatrics. 2017 Feb;139(2):
pubmed: 28115540
Int J Environ Res Public Health. 2019 Mar 30;16(7):
pubmed: 30935027
Addict Behav. 2018 May;80:59-64
pubmed: 29355818
Addict Behav. 2018 Jan;76:343-347
pubmed: 28892771
Tob Control. 2020 Mar 10;:
pubmed: 32156694
J Adolesc Health. 2018 May;62(5):539-547
pubmed: 29499983
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1881-1888
pubmed: 33332300
Tob Control. 2017 Aug 17;:
pubmed: 28818839
Emerg Themes Epidemiol. 2015 Sep 30;12:14
pubmed: 26425136
Prev Med. 2021 Jan;142:106316
pubmed: 33272598
F1000Res. 2018 Dec 10;7:1915
pubmed: 31354936
JAMA. 2015 Aug 18;314(7):700-7
pubmed: 26284721
Drug Alcohol Depend. 2019 Aug 1;201:182-187
pubmed: 31238240
PLoS One. 2018 Mar 14;13(3):e0193328
pubmed: 29538396
Am J Prev Med. 2020 May;58(5):657-665
pubmed: 32147371
Tob Control. 2017 Jul 22;:
pubmed: 28735273
Drug Alcohol Depend. 2019 Aug 1;201:45-48
pubmed: 31181436
Int J Environ Res Public Health. 2021 Jan 05;18(1):
pubmed: 33466304
F1000Res. 2019 Mar 7;8:264
pubmed: 31956397
Eur Respir J. 2018 May 30;51(5):
pubmed: 29848575
Evid Based Ment Health. 2014 Feb;17(1):30
pubmed: 24477535
Am J Public Health. 2021 Feb;111(2):230-246
pubmed: 33351653
Pediatrics. 2019 Feb;143(2):
pubmed: 30617237
Syst Rev. 2015 Oct 22;4:138
pubmed: 26494010
CMAJ. 2017 Oct 30;189(43):E1328-E1336
pubmed: 29084759
Pediatrics. 2018 Dec;142(6):
pubmed: 30397165
BMJ. 2019 Sep 30;366:l5275
pubmed: 31570493
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
JAMA Netw Open. 2020 Jun 1;3(6):e203826
pubmed: 32501490
Pneumologie. 2020 Jan;74(1):39-45
pubmed: 31756736
Tob Control. 2017 Dec;26(e2):e106-e111
pubmed: 28167683
Am J Prev Med. 2019 Dec;57(6):741-748
pubmed: 31668668
Pediatrics. 2016 Jul;138(1):
pubmed: 27296866
Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216
pubmed: 33913154
Addiction. 2021 Apr;116(4):743-756
pubmed: 32888234
Respirology. 2020 Oct;25(10):1082-1089
pubmed: 32713105
Addict Behav. 2020 Apr;103:106243
pubmed: 31855726
Biometrics. 2018 Sep;74(3):785-794
pubmed: 29141096
JAMA Pediatr. 2015 Nov;169(11):1018-23
pubmed: 26348249
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
Am J Public Health. 2016 Nov;106(11):2057-2063
pubmed: 27631743
Prev Med Rep. 2019 Oct 25;16:101011
pubmed: 31890469
Tob Control. 2017 Jan;26(1):34-39
pubmed: 26811353
Pediatrics. 2015 Aug;136(2):308-17
pubmed: 26216326
Drug Alcohol Depend. 2017 Nov 1;180:427-430
pubmed: 28988005
Aust N Z J Public Health. 2018 Jun;42(3):303-308
pubmed: 29528527
Addict Behav. 2017 Apr;67:66-72
pubmed: 28038364
Int J Evid Based Healthc. 2015 Sep;13(3):196-207
pubmed: 26355603
BMJ Open. 2021 Mar 30;11(3):e045603
pubmed: 33785493
Tob Prev Cessat. 2019 Apr 22;5:15
pubmed: 32411879